DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Micardis (Telmisartan) - Adverse Event Reports - Death

 



Index of reports > Cases resulting in death (59)

     Hyperthyroidism (12)Duodenal Ulcer (8)Sepsis (8)Peptic Ulcer (4)Renal Failure Chronic (4)Duodenal Ulcer Perforation (4)Cardiac Arrest (4)Renal Failure Acute (4)

Below is the selection of adverse event reports related to Micardis (Telmisartan) that includes cases resulting in death.

 Reports 1 - 25 of 59   Next >>

Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Brazil on 2007-10-30

Patient: male, weighing 122.0 kg (268.4 pounds)

Adverse reactions / side effects: Renal Failure, Pneumonia, Diarrhoea, Aspiration, Sepsis, Sensory Disturbance, Cardiac Arrest

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Aggrenox
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2006-05-12

Clopidogrel
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2006-05-12

Micardis
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2006-05-12



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-18

Patient: female

Adverse reactions / side effects: Marasmus

Adverse event resulted in: death

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Amlodipine; Pletal



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-18

Patient: male

Adverse reactions / side effects: Brain Stem Haemorrhage, Vomiting, Dizziness

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Aspirin
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2006-02-01
    End date: 2006-07-01

Micardis
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-06-05
    End date: 2006-07-19



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-18

Patient: female

Adverse reactions / side effects: Marasmus

Adverse event resulted in: death

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Amlodipine; Pletal



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-18

Patient: male

Adverse reactions / side effects: Brain Stem Haemorrhage, Vomiting, Dizziness

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Aspirin
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2006-02-01
    End date: 2006-07-01

Micardis
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-06-05
    End date: 2006-07-19



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-18

Patient: male

Adverse reactions / side effects: Brain Stem Haemorrhage, Vomiting, Dizziness

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Aspirin
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2006-02-01
    End date: 2006-07-01

Micardis
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-06-05
    End date: 2006-07-19



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-18

Patient: female

Adverse reactions / side effects: Marasmus

Adverse event resulted in: death

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Amlodipine; Pletal



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-05

Patient: male

Adverse reactions / side effects: Pulmonary Alveolar Haemorrhage, Arteriosclerosis Obliterans

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Famotidine; Uniphyl LA (Theophylline); Mucosolvan L; Resplen; Herbesser R; Aspirin; Basen OD (Voglibose); Ticlopidine HCL; Mucodyne



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-03

Patient: male, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Micardis (Telmisartan)



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-10-02

Patient: female, weighing 49.0 kg (107.8 pounds)

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Micardis (Telmisartan)



Adverse event in female receiving Micardis (Telmisartan)

Reported by a physician from Japan on 2007-07-17

Patient: female, weighing 27.0 kg (59.4 pounds)

Adverse reactions / side effects: Cerebral Haemorrhage

Adverse event resulted in: death, life threatening event

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Ganaton; Etizolam; BIO-Three (Clostridium Butyricum Combined Drug)



Adverse event in 57 year old female receiving Micardis (Telmisartan)

Reported by a physician from Japan on 2007-07-11

Patient: 57 year old female

Adverse reactions / side effects: Cerebral Infarction

Adverse event resulted in: death

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Ganaton; Etizolam; BIO-Three (Clostridium Butyricum Combined Drug)



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Brazil on 2007-07-09

Patient: male, weighing 122.0 kg (268.4 pounds)

Adverse reactions / side effects: Renal Failure, Metabolic Acidosis, Diarrhoea, Aspiration, Sepsis, Sensory Disturbance, Cardiac Arrest

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Aggrenox
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2006-05-12

Clopidogrel
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2006-05-12

Micardis
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2006-05-12



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-07-09

Patient: female

Adverse reactions / side effects: Myelodysplastic Syndrome

Adverse event resulted in: death

Suspect drug(s):
Micardis (Telmisartan)



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-07-09

Patient: female

Adverse reactions / side effects: Marasmus

Adverse event resulted in: death

Suspect drug(s):
Micardis (Telmisartan)



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-07-05

Patient: female, weighing 34.3 kg (75.5 pounds)

Adverse reactions / side effects: Chest Pain, Sudden Death

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Lasix; Warfarin Sodium; Digoxin; Millis (Nitroglycerin); Aspirin; Novorapid



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Germany on 2007-06-29

Patient: female, weighing 90.0 kg (198.0 pounds)

Adverse reactions / side effects: Pulmonary Embolism, Cholecystectomy

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Micardis (Telmisartan)



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-06-15

Patient: female, weighing 34.3 kg (75.5 pounds)

Adverse reactions / side effects: Chest Pain, Sudden Death

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Lasix; Warfarin Sodium; Digoxin; Millis (Nitroglycerin); Aspirin; Novorapid



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-06-08

Patient: female

Adverse reactions / side effects: Pruritus, Sudden Death

Adverse event resulted in: death

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Alfasuly (Alfacalcidol); Sennoside (Sennoside); Cetilo



Adverse event in female receiving Micardis (Telmisartan)

Reported by a health professional (non-physician/pharmacist) from Malaysia on 2007-06-06

Patient: female

Adverse reactions / side effects: Sepsis, Duodenal Ulcer, Renal Failure Chronic, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Aggrenox
    Dosage: 200mg/25mg bid
    Administration route: Oral
    Indication: Cerebrovascular Accident
    Start date: 2004-12-28
    End date: 2007-03-16

Clopidogrel
    Administration route: Oral
    Indication: Cerebrovascular Accident
    Start date: 2004-12-28
    End date: 2007-03-16

Micardis
    Administration route: Oral
    Indication: Cerebrovascular Accident
    Start date: 2004-12-28
    End date: 2007-03-12



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-06-04

Patient: male, weighing 54.0 kg (118.8 pounds)

Adverse reactions / side effects: Sudden Death

Adverse event resulted in: death

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Bezatol SR



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Malaysia on 2007-06-01

Patient: female, weighing 55.0 kg (121.0 pounds)

Adverse reactions / side effects: Sepsis, Duodenal Ulcer, Renal Failure Chronic, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Aggrenox
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2004-12-28
    End date: 2007-03-16

Clopidogrel
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2004-12-28
    End date: 2007-03-16

Micardis
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2004-12-28
    End date: 2007-03-12

Other drugs received by patient: Cloxacillia; Tazocin; Fortum



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-05-31

Patient: female

Adverse reactions / side effects: Pruritus, Sudden Death

Adverse event resulted in: death

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Alfasuly (Alfacalcidol); Sennoside (Sennoside); Cetilo



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-05-29

Patient: female, weighing 34.3 kg (75.5 pounds)

Adverse reactions / side effects: Back Pain, Diet Refusal, Hypoglycaemia, Dementia, Chest Pain, Sudden Death, Cardiac Arrest, Myocardial Infarction

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Lasix; Warfarin Sodium; Digoxin; Millis (Nitroglycerin); Aspirin; Novorapid



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Japan on 2007-05-25

Patient: female

Adverse reactions / side effects: Pruritus, Sudden Death

Adverse event resulted in: death

Suspect drug(s):
Micardis (Telmisartan)

Other drugs received by patient: Alfasuly (Alfacalcidol); Sennoside (Sennoside); Cetilo



 Page 1   Next >>

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009